Literature DB >> 9518487

Efficient directional cloning of recombinant adenovirus vectors using DNA-protein complex.

T Okada1, W J Ramsey, J Munir, O Wildner, R M Blaese.   

Abstract

We describe an efficient cloning system utilizing adenoviral DNA-protein complexes which allows the directional cloning of genes into adenoviral expression vectors in a single step. DNA-protein complexes derived from a recombinant adenovirus (AVC2.null) were isolated by sequential use of CsCl step gradients followed by isopycnic centrifugation in a mixture of CsCl and guanidine HCl. AVC2.null is an adenoviral expression vector containing unique restriction sites between the human CMV-IE promoter and the SV40 intron/polyadenylation site. Transgenes were prepared for cloning into this vector by introduction of compatible restriction sites by PCR. A vector expressing rat granulocyte-macrophage colony-stimulating factor (GM-CSF) was constructed using DNA-protein complex as well as by traditional recombination techniques. The efficacy of our adenoviral cloning system utilizing DNA-protein complex was two logs higher than that seen using homologous recombination. All viruses generated by directional ligation of the insert into the vector DNA-protein complexes contained the desired transgene in the correct orientation. This technique greatly simplifies and accelerates the generation of recombinant adenoviral vectors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9518487      PMCID: PMC147483          DOI: 10.1093/nar/26.8.1947

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  18 in total

1.  The infectivity of adenovirus 5 DNA-protein complex.

Authors:  P A Sharp; C Moore; J L Haverty
Journal:  Virology       Date:  1976-12       Impact factor: 3.616

Review 2.  Adenovirus-based expression vectors and recombinant vaccines.

Authors:  F L Graham; L Prevec
Journal:  Biotechnology       Date:  1992

3.  Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis.

Authors:  R G Crystal; N G McElvaney; M A Rosenfeld; C S Chu; A Mastrangeli; J G Hay; S L Brody; H A Jaffe; N T Eissa; C Danel
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

4.  Gut epithelial cells as targets for gene therapy of hemophilia.

Authors:  J N Lozier; J R Yankaskas; W J Ramsey; L Chen; H Berschneider; R A Morgan
Journal:  Hum Gene Ther       Date:  1997-08-10       Impact factor: 5.695

5.  A circula DNA-protein complex from adenoviruses.

Authors:  A J Robinson; H B Younghusband; A J Bellett
Journal:  Virology       Date:  1973-11       Impact factor: 3.616

6.  A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5.

Authors:  W J McGrory; D S Bautista; F L Graham
Journal:  Virology       Date:  1988-04       Impact factor: 3.616

7.  Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis.

Authors:  W W Zhang; X Fang; C D Branch; W Mazur; B A French; J A Roth
Journal:  Biotechniques       Date:  1993-11       Impact factor: 1.993

8.  Isolation of deletion and substitution mutants of adenovirus type 5.

Authors:  N Jones; T Shenk
Journal:  Cell       Date:  1978-01       Impact factor: 41.582

Review 9.  Current use and future directions of adenovirus vaccine.

Authors:  M J Gurwith; G S Horwith; C A Impellizzeri; A R Davis; M D Lubeck; P P Hung
Journal:  Semin Respir Infect       Date:  1989-12

Review 10.  Adenovirus-mediated in vivo gene transfer.

Authors:  S L Brody; R G Crystal
Journal:  Ann N Y Acad Sci       Date:  1994-05-31       Impact factor: 5.691

View more
  5 in total

1.  Long-term engraftment of multipotent mesenchymal stromal cells that differentiate to form myogenic cells in dogs with Duchenne muscular dystrophy.

Authors:  Yuko Nitahara-Kasahara; Hiromi Hayashita-Kinoh; Sachiko Ohshima-Hosoyama; Hironori Okada; Michiko Wada-Maeda; Akinori Nakamura; Takashi Okada; Shin'ichi Takeda
Journal:  Mol Ther       Date:  2011-09-20       Impact factor: 11.454

2.  Transcriptional repression of Caveolin-1 (CAV1) gene expression by GATA-6 in bladder smooth muscle hypertrophy in mice and human beings.

Authors:  Ettickan Boopathi; Cristiano Mendes Gomes; Robert Goldfarb; Mary John; Vittala Gopal Srinivasan; Jaber Alanzi; S Bruce Malkowicz; Hasmeena Kathuria; Stephen A Zderic; Alan J Wein; Samuel Chacko
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

3.  High-efficiency system for the construction of adenovirus vectors and its application to the generation of representative adenovirus-based cDNA expression libraries.

Authors:  Moritz Hillgenberg; Christian Hofmann; Herbert Stadler; Peter Löser
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides.

Authors:  Lars Steinstraesser; Bettina Tippler; Janine Mertens; Evert Lamme; Heinz-Herbert Homann; Marcus Lehnhardt; Oliver Wildner; Hans-Ulrich Steinau; Klaus Uberla
Journal:  Retrovirology       Date:  2005-01-18       Impact factor: 4.602

5.  Current Challenges and Future Directions in Recombinant AAV-Mediated Gene Therapy of Duchenne Muscular Dystrophy.

Authors:  Takashi Okada; Shin'ichi Takeda
Journal:  Pharmaceuticals (Basel)       Date:  2013-06-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.